Defining Pharyngeal and Upper Esophageal Sphincter Disorders on High-Resolution Manometry-Impedance: The Leuven Consensus.

TitleDefining Pharyngeal and Upper Esophageal Sphincter Disorders on High-Resolution Manometry-Impedance: The Leuven Consensus.
Publication TypeJournal Article
Year of Publication2026
AuthorsOmari TI, Maclean JCF, Cock C, McCulloch TM, Nativ-Zeltzer N, O'Rourke AK, Szczesniak MM, Wu PI, Allen J, Aoyagi Y, Bayona HHenrian G, Carrión S, Ciucci MR, Davidson K, Dhar SI, Hamdy S, Howell R, Jones C, Knigge MA, Moonen A, Postma GN, Puntil-Sheltman J, Rameau A, Regan J, Schar M, Rommel N
JournalNeurogastroenterol Motil
Volume38
Issue4
Paginatione70042
Date Published2026 Apr
ISSN1365-2982
KeywordsConsensus, Deglutition Disorders, Electric Impedance, Esophageal Motility Disorders, Esophageal Sphincter, Upper, Humans, Manometry
Abstract

INTRODUCTION: The Leuven Consensus provides a classification scheme for the diagnosis of pharyngeal and upper esophageal sphincter (UES) motor disorders using metrics derived from pharyngeal high-resolution manometry-impedance (P-HRM-I).

METHODS: Twenty-six experts with broad multidisciplinary backgrounds contributed their knowledge and experience to this initiative via a formal deliberative Delphi process. Guidance on a swallow assessment protocol as well as diagnostic criteria for UES dysfunction and pharyngeal contractile dysfunction is provided.

RESULTS: For UES dysfunction, the stepwise evaluation of UES and intrabolus pressure metrics under increasing bolus volume and/or viscosity conditions is used to confirm failure of manometric relaxation and opening of the UES region. For pharyngeal contractile dysfunction, the evaluation of contractile metrics is used to define pharyngeal hypocontractility or hypercontractility.

CONCLUSION: These recommendations complement routine instrumental investigations and provide a standardized process, criteria, and nomenclature for P-HRM-I assessment of patients reporting symptoms of oropharyngeal dysphagia.

DOI10.1111/nmo.70042
Alternate JournalNeurogastroenterol Motil
PubMed ID40202098
PubMed Central IDPMC13121872
Grant List / / Laborie Medical Technologies /
/ / Dr Falk Pharma provided an unrestricted educational grant /